Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 1999 Apr;75(2):107–111. doi: 10.1136/sti.75.2.107

Susceptibility of gonococci isolated in London to therapeutic antibiotics: establishment of a London surveillance programme. London Gonococcal Working Group

C A Ison, I M Martin
PMCID: PMC1758195  PMID: 10448363

Abstract

OBJECTIVES: To establish the in vitro susceptibility of gonococci isolated in the London area to antibiotics in current therapeutic use and to establish a sentinel surveillance system for monitoring trends in antibiotic resistant gonorrhoea in London. METHODS: Isolates of Neisseria gonorrhoeae from consecutive patients attending genitourinary medicine clinics at 10 hospitals in the London area were collected over a 3 month period, May to July 1997. The susceptibility to penicillin, ciprofloxacin, tetracycline, and spectinomycin was determined for each isolate. Isolates exhibiting either plasmid or chromosomally mediated resistance were additionally tested for susceptibility to agents used as alternative treatments including azithromycin, ceftriazone, and ofloxacin. The resistant isolates were also tested for plasmid profiles (penicillinase producing N gonorrhoeae, PPNG), type of tetM determinant (tetracycline resistant N gonorrhoeae, TRNG), and presence of gyrA and parC mutations (quinolone resistant N gonorrhoeae, QRNG). RESULTS: A total of 1133 isolates were collected which represents > 95% of the total gonococci isolated in the 3 months. Plasmid mediated resistance was exhibited by 48 (4.2%) isolates; six (0.5%) were PPNG, 15 (1.3%) were PP/TRNG, and 27 (2.4%) were TRNG. The majority of PPNG (18 of 20 tested) carried the 3.2 MDa penicillinase plasmid whereas the two types of tetM determinant were more evenly distributed. High level resistance to ciprofloxacin was detected in four (0.4%) isolates and double mutations were found in the quinolone resistance determining region (QRDR) of the gyrA gene in three QRNG with MICs of 16 mg/l and a single mutation in one isolate with a MIC of 1 mg/l to ciprofloxacin. No parC mutations were found. Of the remaining 1081 isolates, 86 (8.0%) were chromosomally mediated resistant N gonorrhoeae (CMRNG). CONCLUSIONS: A unique collection of gonococcal isolates has been established which can be used as a baseline for surveillance of susceptibility to antibiotics and for epidemiological purposes. 




Full Text

The Full Text of this article is available as a PDF (88.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bindayna K. M., Ison C. A. Sampling methods for monitoring changes in gonococcal populations. Epidemiol Infect. 1989 Aug;103(1):203–209. doi: 10.1017/s0950268800030508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Birnboim H. C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 1979 Nov 24;7(6):1513–1523. doi: 10.1093/nar/7.6.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burn S., Horner P. J. Rectal gonorrhoea as an independent risk factor for HIV infection in homosexual males. Genitourin Med. 1995 Oct;71(5):335–336. doi: 10.1136/sti.71.5.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Catchpole M. A. The role of epidemiology and surveillance systems in the control of sexually transmitted diseases. Genitourin Med. 1996 Oct;72(5):321–329. doi: 10.1136/sti.72.5.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Craib K. J., Meddings D. R., Strathdee S. A., Hogg R. S., Montaner J. S., O'Shaughnessy M. V., Schechter M. T. Rectal gonorrhoea as an independent risk factor for HIV infection in a cohort of homosexual men. Genitourin Med. 1995 Jun;71(3):150–154. doi: 10.1136/sti.71.3.150. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Evans B. G., Catchpole M. A., Heptonstall J., Mortimer J. Y., McCarrigle C. A., Nicoll A. G., Waight P., Gill O. N., Swan A. V. Sexually transmitted diseases and HIV-1 infection among homosexual men in England and Wales. BMJ. 1993 Feb 13;306(6875):426–428. doi: 10.1136/bmj.306.6875.426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FitzGerald M., Bedford C. National standards for the management of gonorrhoea. Int J STD AIDS. 1996 Jul;7(4):298–300. doi: 10.1258/0956462961917861. [DOI] [PubMed] [Google Scholar]
  8. Fitzgerald M. Antibiotic treatment for gonorrhoea in the UK. Genitourin Med. 1997 Apr;73(2):149–149. doi: 10.1136/sti.73.2.149-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gascoyne-Binzi D. M., Heritage J., Hawkey P. M. Nucleotide sequences of the tet(M) genes from the American and Dutch type tetracycline resistance plasmids of Neisseria gonorrhoeae. J Antimicrob Chemother. 1993 Nov;32(5):667–676. doi: 10.1093/jac/32.5.667. [DOI] [PubMed] [Google Scholar]
  10. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  11. Hughes G., Simms I., Rogers P. A., Swan A. V., Catchpole M. New cases seen at genitourinary medicine clinics: England 1997. Commun Dis Rep CDR Suppl. 1998 Dec;8(7):S1–11. [PubMed] [Google Scholar]
  12. Ison C. A. Antimicrobial agents and gonorrhoea: therapeutic choice, resistance and susceptibility testing. Genitourin Med. 1996 Aug;72(4):253–257. doi: 10.1136/sti.72.4.253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ison C. A., Branley N. S., Kirtland K., Easmon C. S. Surveillance of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae. BMJ. 1991 Nov 23;303(6813):1307–1307. doi: 10.1136/bmj.303.6813.1307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ison C. A., Dillon J. A., Tapsall J. W. The epidemiology of global antibiotic resistance among Neisseria gonorrhoeae and Haemophilus ducreyi. Lancet. 1998;351 (Suppl 3):8–11. doi: 10.1016/s0140-6736(98)90003-4. [DOI] [PubMed] [Google Scholar]
  15. Ison C. A., Tekki N., Gill M. J. Detection of the tetM determinant in Neisseria gonorrhoeae. Sex Transm Dis. 1993 Nov-Dec;20(6):329–333. [PubMed] [Google Scholar]
  16. Ison C. A., Woodford P. J., Madders H., Claydon E. Drift in susceptibility of Neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure. Antimicrob Agents Chemother. 1998 Nov;42(11):2919–2922. doi: 10.1128/aac.42.11.2919. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Low N., Daker-White G., Barlow D., Pozniak A. L. Gonorrhoea in inner London: results of a cross sectional study. BMJ. 1997 Jun 14;314(7096):1719–1723. doi: 10.1136/bmj.314.7096.1719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McCormack W. M. Penicillinase-producing Neisseria gonorrhoeae--a retrospective. N Engl J Med. 1982 Aug 12;307(7):438–439. doi: 10.1056/NEJM198208123070712. [DOI] [PubMed] [Google Scholar]
  19. McCutchan J. A., Adler M. W., Berrie J. R. Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission. Br Med J (Clin Res Ed) 1982 Jul 31;285(6338):337–340. doi: 10.1136/bmj.285.6338.337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Schwarcz S. K., Zenilman J. M., Schnell D., Knapp J. S., Hook E. W., 3rd, Thompson S., Judson F. N., Holmes K. K. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA. 1990 Sep 19;264(11):1413–1417. [PubMed] [Google Scholar]
  22. Xia M., Pang Y., Roberts M. C. Detection of two groups of 25.2 MDa Tet M plasmids by polymerase chain reaction of the downstream region. Mol Cell Probes. 1995 Oct;9(5):327–332. doi: 10.1016/s0890-8508(95)91620-2. [DOI] [PubMed] [Google Scholar]
  23. Young H., Moyes A., McKenna J. G., McMillan A. Rectal gonorrhoea and unsafe sex. Lancet. 1991 Apr 6;337(8745):853–853. doi: 10.1016/0140-6736(91)92561-f. [DOI] [PubMed] [Google Scholar]
  24. van de Laar M. J., van Duynhoven Y. T., Dessens M., van Santen M., van Klingeren B. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95. Genitourin Med. 1997 Dec;73(6):510–517. doi: 10.1136/sti.73.6.510. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES